CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Option exercise Director acquired 21,000 shares (option exercise)
- 4 Planned sale President and CEO sold 20,559 shares at $3.84 ($78,947)
- 4 Planned sale Chief Financial Officer sold 8,149 shares at $3.84 ($31,292)
- 4 Planned sale General Counsel and Secretary sold 4,925 shares at $3.84 ($18,912)
- 4 Planned sale Chief Research Officer sold 4,925 shares at $3.84 ($18,912)
- 4 Planned sale President and CEO sold 34,799 shares at $4.17 ($145,112)
- 4 Planned sale General Counsel and Secretary sold 8,854 shares at $4.03 ($35,682)
- 4 Planned sale Chief Financial Officer sold 15,213 shares at $4.03 ($61,308)
- 4 Planned sale Chief Research Officer sold 10,200 shares at $4.03 ($41,106)
- 4 Open-market buy Director bought 3,000 shares at $4.72 ($14,160)
- 4 Open-market buy Director bought 2,700 shares at $4.70 ($12,690)
- 4 Open-market buy Director bought 1,381 shares at $4.97 ($6,864)
- 4 Planned sale Chief Financial Officer sold 1,303 shares at $6.49 ($8,456)
- 4 Planned sale General Counsel and Secretary sold 665 shares at $6.49 ($4,316)
- 4 Planned sale President and CEO sold 3,409 shares at $6.49 ($22,124)
- 4 Open-market buy Director bought 2,700 shares at $4.97 ($13,419)
- 4 Open-market buy Director bought 1,400 shares at $4.89 ($6,846)
- 4 Planned sale Chief Financial Officer sold 14,827 shares at $4.26 ($63,163)
- 4 Open-market buy Director bought 1,682 shares at $4.14 ($6,963)
- 4 Open-market buy Director bought 5,076 shares at $4.16 ($21,116)
Page 2 of 14 · 269 filings